No Data
Beijing Scitop Bio-tech (300858.SZ): Kairunda has cumulatively reduced its shareholding by 1%.
On December 13, Glonghui reported that Beijing Scitop Bio-tech (300858.SZ) announced that the company recently received a notification from Kerongda regarding the Shareholding reaching 1%. From November 29, 2024, to December 12, 2024, it reduced its shares by 400,000 shares through Trade transactions and by 2,235,000 shares through centralized bidding, totaling a Shareholding reduction of 1.0000%.
Cotuo Biotech: Report for the third quarter of 2024
Beijing Scitop Bio-Tech (300858.SZ): The net income in the first three quarters was 71.1909 million yuan, a year-on-year decrease of 1.13%.
Gelonghui October 29th | Beijing Scitop Bio-Tech (300858.SZ) announced its third quarter report for 2024, with the company achieving revenue of 0.219 billion yuan in the first three quarters, a year-on-year increase of 0.81%; net income attributable to shareholders of the listed company was 71.1909 million yuan, a year-on-year decrease of 1.13%; net income attributable to shareholders of the listed company excluding non-recurring gains and losses was 61.0979 million yuan, a year-on-year increase of 0.30%; basic earnings per share of 0.27 yuan.
Beijing Scitop Bio-Tech (300858.SZ): Probiotic products can be used in pet food ingredients
According to Beijing Scitop Bio-Tech (300858.SZ), probiotic products of the company can be used as ingredients in pet food on the investor interaction platform on October 11th.
Beijing Scitop Bio-Tech (300858.SZ): The food sector R&D and production base project is expected to achieve the designated usable status on June 30, 2025.
Beijing Scitop Bio-tech (300858.SZ) stated on the investor interaction platform on September 20 that the R&D and production base project in the food sector is expected to reach the planned usable state on June 30, 2025. Currently, construction work is underway, and relevant contracts with major equipment suppliers have been signed.
Beijing Scitop Bio-tech (300858.SZ): Postbiotic products can be applied in snack food, daily chemical products, beauty and female personal care products.
Ketuo Biology (300858.SZ) stated on the investor interaction platform that postbiotics refers to genetically defined inactivated microorganisms and/or bacterial components that are beneficial to the host's health, including or excluding their metabolic products; excluding chemically synthesized components and viruses/bacteriophage and their products. Currently, the company's postbiotic products can be applied in snack food, daily chemicals, cosmetics, and female personal care products.
